UnitedHealth Group (NYSE:UNH) Stock Rating Reaffirmed by Cantor Fitzgerald

UnitedHealth Group (NYSE:UNH)‘s stock had its “overweight” rating reissued by Cantor Fitzgerald in a research note issued on Tuesday, Benzinga reports. They presently have a $591.00 price objective on the healthcare conglomerate’s stock. Cantor Fitzgerald’s price target points to a potential upside of 0.45% from the stock’s current price.

Several other analysts have also recently weighed in on UNH. Truist Financial lifted their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and increased their price objective for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. TD Cowen upped their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. HSBC boosted their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Finally, Royal Bank of Canada lifted their target price on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $614.17.

UnitedHealth Group Trading Up 0.6 %

Shares of NYSE UNH traded up $3.68 during midday trading on Tuesday, reaching $588.36. The company had a trading volume of 927,888 shares, compared to its average volume of 3,972,937. The firm’s fifty day moving average price is $579.93 and its 200-day moving average price is $525.06. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group has a one year low of $436.38 and a one year high of $607.94. The stock has a market cap of $543.30 billion, a PE ratio of 35.90, a price-to-earnings-growth ratio of 1.62 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter in the previous year, the company earned $6.14 earnings per share. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, equities research analysts anticipate that UnitedHealth Group will post 27.69 earnings per share for the current year.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

A number of hedge funds have recently modified their holdings of the company. Edge Capital Group LLC increased its holdings in UnitedHealth Group by 1.0% in the 4th quarter. Edge Capital Group LLC now owns 2,906 shares of the healthcare conglomerate’s stock valued at $1,530,000 after purchasing an additional 29 shares during the last quarter. Capital Research Global Investors raised its holdings in shares of UnitedHealth Group by 2.2% in the 4th quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock valued at $7,961,369,000 after buying an additional 324,733 shares during the period. Amussen Hunsaker Associates LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $203,000. Tower Research Capital LLC TRC increased its stake in UnitedHealth Group by 365.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 142,228 shares of the healthcare conglomerate’s stock worth $74,879,000 after purchasing an additional 111,659 shares during the period. Finally, Alapocas Investment Partners Inc. boosted its stake in shares of UnitedHealth Group by 0.7% in the fourth quarter. Alapocas Investment Partners Inc. now owns 14,982 shares of the healthcare conglomerate’s stock valued at $7,888,000 after purchasing an additional 99 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.